Expected earnings - Helix Biopharma Corp.
Source: US Earnings Reports
Helix Biopharma Corp. (HBPCF) is expected to report for Q3 2025
Helix Biopharma Corp
NASDAQ: HBPCF
HBPCF Trading
222.51% G/L:
$1.7338 Last:
480 Volume:
$1.7266 Open:
HBPCF Latest News
February 24, 2026 09:00:00 am
Helix BioPharma Corp. Announces Presentation at 16th Annual World ADC London
February 05, 2026 04:30:00 pm
Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases
HBPCF Stock Data
$104,197,388
75,324,080
0.06%
20
N/A
Biotechnology & Life Sciences
Healthcare
CA
Toronto
